Arcellx (ACLX) Accumulated Expenses (2021 - 2025)
Arcellx (ACLX) recorded quarterly Accumulated Expenses of $35.1 million in Q4 2025, up 233.04% quarter-over-quarter from $10.5 million in Q3 2025, and down 38.15% on a YoY basis from $56.7 million in Q4 2024.
Arcellx (ACLX) Accumulated Expenses (2021 - 2025) Analysis & Trends
Arcellx's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $35.1 million for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 38.15% year-over-year to $35.1 million; the TTM figure through Dec 2025 stood at $35.1 million (down 38.15% YoY), while the FY2025 annual figure was $35.1 million, down 38.15% from the prior year.
- Accumulated Expenses was $35.1 million for Q4 2025 at Arcellx, up from $10.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $56.7 million in Q4 2024 to a low of $793000.0 in Q1 2022.
- Historically, Accumulated Expenses has averaged $17.1 million across 5 years, with a median of $11.7 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses jumped 1665.07% in 2023, then sank 82.29% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $1.3 million in 2021, then soared by 797.69% to $11.7 million in 2022, then soared by 56.71% to $18.3 million in 2023, then surged by 209.89% to $56.7 million in 2024, then tumbled by 38.15% to $35.1 million in 2025.
- The last three Accumulated Expenses figures came in at $35.1 million (Q4 2025), $10.5 million (Q3 2025), and $53.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.08 Mn |
| Sep 30, 2025 | 10.53 Mn |
| Jun 30, 2025 | 53.03 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 56.72 Mn |
| Sep 30, 2024 | 43.04 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 18.30 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 2.65 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Dec 31, 2022 | 11.68 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 13.73 Mn |
| Mar 31, 2022 | 793,000.00 |
| Dec 31, 2021 | 1.30 Mn |